These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 10565771

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, Takekuma M, Maeda M, Ouchi Y.
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [Abstract] [Full Text] [Related]

  • 23. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.
    Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U.
    Eur J Nucl Med; 1997 Jun; 24(6):678-82. PubMed ID: 9169578
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E.
    J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.
    Hu SL, Yang ZY, Zhou ZR, Yu XJ, Ping B, Zhang YJ.
    Nucl Med Commun; 2013 Jun; 34(6):533-9. PubMed ID: 23503000
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.
    Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y.
    World J Gastroenterol; 2008 Jan 07; 14(1):64-9. PubMed ID: 18176963
    [Abstract] [Full Text] [Related]

  • 35. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC, Bühler L, Bucher P, Willi JP, Frossard JL, Roth AD, Addeo P, Rosset A, Terraz S, Becker CD, Ratib O, Morel P.
    J Gastroenterol Hepatol; 2011 Apr 07; 26(4):657-62. PubMed ID: 21155879
    [Abstract] [Full Text] [Related]

  • 36. Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
    Buck AC, Schirrmeister HH, Guhlmann CA, Diederichs CG, Shen C, Buchmann I, Kotzerke J, Birk D, Mattfeldt T, Reske SN.
    J Nucl Med; 2001 May 07; 42(5):721-5. PubMed ID: 11337566
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors].
    Valinas R, Barrier A, Montravers F, Houry S, Talbot JN, Huguier M.
    Gastroenterol Clin Biol; 2002 Oct 07; 26(10):888-92. PubMed ID: 12434099
    [Abstract] [Full Text] [Related]

  • 40. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
    Sperti C, Pasquali C, Fiore V, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S.
    Am J Surg; 2006 Jun 07; 191(6):743-8. PubMed ID: 16720142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.